Health-care companies ticked down as traders rotated into more interest-rate sensitive sectors.
Novo Nordisk shares slipped as the Danish obesity-drug maker remained under pressure. Drugmaker Endo International won court approval for its bankruptcy plan to eliminate $5.5 billion in debt and resolve thousands of lawsuits related to its opioids and other products.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
03-20-24 1740ET
